Home ›› Cancer Programs ›› Lung Esophageal Cancer ›› Clinical Trials for Lung and Esophageal Cancer

Lung and Esophageal Cancer Clinical trials are research studies in which people help doctors find ways to improve health and cancer care. Each study tries to answer scientific questions and to find better ways to prevent, diagnose or treat cancer. It is designed to show how a particular anticancer strategy - a promising drug, a gene therapy treatment, a new diagnostic test, or a possible way to prevent cancer - affects the people who receive it.

For more information about lung and esophageal cancer clinical trials, or to schedule an appointment, call (407) 303-1700 or click here to fill out an online assistance form.

Current Lung and Esophageal Cancer Clinical Trials by Diagnosis

Click on the links below to view lung and esophageal cancer clinical trials available by diagnosis:

Back to Top

New Treatments Offer Hope for Lung and Esophageal Cancer

When lung or esophageal cancer is the diagnosis, many patients of the Florida Hospital Cancer Institute (FHCI) want to explore every option available to them regarding their treatment.

In many cases, you may be a good candidate for lung or esophageal cancer clinical trials. After weighing all the options, your physician may suggest you consider one of the many clinical trials being conducted in the area of thoracic cancer. Our team is highly trained in all types of thoracic cancer care and many of our specialists are at the forefront of conducting clinical trials for thoracic cancer, including lung cancer, esophageal cancer and mesothelioma.

Lung and Esophageal Cancer Clinical trials can last for years. Like any traditional treatment, there are risks and benefits that depend on the course of treatment and the individual. However, physicians at the FHCI adhere to rigorous guidelines and you will be informed of these factors before you participate in any clinical trial. In many cases, there are no extraneous costs to you for participating in a research program. Often, clinical trials and the extra tests required are provided at no cost to you. Again, your doctor will go over everything with you before treatment begins.

For more information about lung and esophageal cancer clinical trials, or to schedule an appointment, call (407) 303-1700 or click here to fill out an online assistance form.

Back to Top

Benefits of Lung and Esophageal Cancer Clinical Trials

While clinical trials help evaluate new treatment options for lung cancer and esophageal cancer, they aren't for everyone. But if you are a good candidate for one, you can help test the safety and effectiveness of the new generations of cancer drugs in development, new approaches to surgery or radiation therapy and new combinations of treatment. While there is no guarantee a treatment will ultimately be successful, the results of many clinical trials of past years are now standard practice in medicine. If a clinical trial cancer treatment does prove effective, obviously you're one of the first to benefit from it.

Other benefits include:

  • Access to state-of-the-art treatments for lung and esophageal cancer.
  • Dedicated care by a research nurse who is involved in every aspect of your treatment, care and follow-up.
  • Making a contribution to finding better ways to prevent, detect and treat cancer.

The Florida Hospital Cancer Institute is one of the most active participants in lung and esophageal clinical trials in the nation. Many of our partners are household names, including the National Cancer Institute, Duke University Medical Center, the UCLA Community Oncology Research Network and many highly respected pharmaceutical companies. In many cases we are the only institution in the entire Southeast region to offer such trials.

Florida Hospital Cancer Institute is an affiliated member of the Radiation Therapy Oncology Group® (RTOG®) with University of Alabama. The Radiation Therapy Oncology Group® (RTOG®) has been a recognized leader in working to increase survival and improve the quality of life for cancer patients. RTOG is a key clinical research component of the American College of Radiology (ACR) and serves as a multi-institutional, international clinical cooperative group funded primarily by the National Cancer Institute.

 

Back to Top

Request an Appointment

For more information about lung and esophageal cancer clinical trials, or to schedule an appointment, call (407) 303-1700 or click here to fill out an online assistance form.

Back to Top